Changes in coagulation patterns, blood loss and blood use after cardiopulmonary bypass: Aprotinin vs tranexamic acid vs epsilon aminocaproic acid

Journal of Cardiovascular Surgery

Volumn 37, Issue 4, 1996, Pages 401-407

  Menichetti, A ^a   Tritapepe, L ^a   Ruvolo, G ^a   Speziale, G ^a,b   Cogliati, A ^a   Di Giovanni, C ^a   Pacilli, M ^a   Criniti, A ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b NONE   (Italy)

Author keywords

Cardiopulmonary bypass; Coagulation; Heart surgery

Indexed keywords

AMINOCAPROIC ACID; ANTIFIBRINOLYTIC AGENT; ANTITHROMBIN III; APROTININ; BLOOD CLOTTING FACTOR 8; FIBRINOGEN; HEMOGLOBIN; PLASMINOGEN; THROMBOPLASTIN; TRANEXAMIC ACID;

ADULT; AGED; ARTICLE; BLOOD CLOTTING; BLOOD CLOTTING TIME; BLOOD TRANSFUSION; CARDIOPULMONARY BYPASS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY BYPASS SURGERY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE HEMORRHAGE; PROTHROMBIN TIME; RANDOMIZED CONTROLLED TRIAL; RISK; THROMBOPLASTIN TIME;

6-AMINOCAPROIC ACID; APROTININ; BLOOD COAGULATION; BLOOD LOSS, SURGICAL; BLOOD TRANSFUSION; CARDIOPULMONARY BYPASS; CORONARY ARTERY BYPASS; FEMALE; HEMOSTATICS; HUMANS; MALE; MIDDLE AGED; POSTOPERATIVE HEMORRHAGE; TRANEXAMIC ACID;

EID: 0030016212     PISSN: 00219509     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Harker LA. Bleeding after cardiopulmonary bypass N Engl J Med 1986,314:1146-448
2. Condo NI, Maddi R, Ewenstein B, Goldhaber SZ Anticoagulation and hemostasis in cardiac surgical patients. J Cardiovasc Surg 1994,9.443-61
3. Woodman RC, Harker LA Bleeding complications associated with cardiopulmonary bypass Blood 1990;76:1680-97
4. Campbell FW, Jobes DR, Eclison N. Coagulation management during and after cardiopulmonary bypass. In. Hensley FAJ, Martin DE. editors The practice of cardiac anethesia Little. Brown Company, 1980 456-79
5. Soomyung Lee. Hemtologic disorders following cardiopulmonary bypass In: Casthely PA, Bregman D, editors. Cardiopulmonary bypass physiology, related complications and pharmacology. Mountkisco, N.Y.: Futura Publishing Company Inc., 1991:191-225.
6. Spiess BD. The contribution of fibrinolysis to post bypass bleeding. J Cardiothorac Anesth 1991;5(Suppl 1).13-7.
7. Hardy GF, Desroches J. Natural and synthetic antifibrinolities in cardiac surgery Can J Anesth 1992;39 353-65
8. Harrow JC, Hlavacek J, Strong MD et al. Prophylactic tramexamic acid decreases bleeding after cardiac operations J Thorac Cardiovasc Surg 1990,99.70-4.
9. Vander Salm TJ, Ansell JE, Okike ON et al. The role of epsilon-aminocaproic acid in reducing bleeding after cardiac operation-a double-blind randomized study. J Thorac Vardiovasc Surg 1988,95 538-40.
10. Caser LCS. Mediastinal bleeding after cardiac surgery: etiologies, diagnostic consideration, and blood conservation methods. J Cardiothorac Anesth 1989;3:760-75.
11. Bildstrup BP, Royston D, Sapsford RN, Taylor KM Reduction in blood loss and blood use after cardiopulmonary bypass with high dose aprotinin (Trasylol). J Thorac Cardiovasc Surg 1989;97:364-72.
12. Dietrich W, Barankay A, Hahuel C, Richter JA. High-dose aprotmin in cardiac surgery: three years experience in 1784 patients. J Cardiothorac Anesth 1992;6:324-7.
13. Dietrich W, Spannagel H. Pochepm H et al. Influence of high-dose aprotinin treatment on blood loss and coagulation patterns in patients undergoing myocardiol revascularization. Anesthesiology 1990;73:1119-26.
14. Dietrich W, Barankay A, Dilthey G et al Reduction of homologous blood requirement in cardiac surgery by intraoperative aprotinin application Clinical experience in 152 cardiac surgical patients. Thorac Cardiovasc Surg 1989,37 92-8.
15. Harder MP, Eijsman L, Roozendal KJ, Van Oaveren W, Wildevuur CRH Aprotinin reduces intraoperative and postoperative blood loss in membrane oxygenator cardiopulmonary bypass. Ann Thorac Surg 1991.51:936-41.
16. Isetta C, Somat C, Kotaiche M, Sancher B, Jourdan J, Grimand D. Reduction des besoins trasfusion mel homologues en chirurgie cardiaque sons aprotinine et sons acide tranexanique. A Freanc d'Anesth Reanim 1991,10:R122.
17. Marx G, Pokar H, Renter H, Doering V, Tilsner V The effects of aprotinin on hemostatic function during cardiac surgery. J Cardiothorac Anesth 1991,5:467-74
18. Leslen G, Horrow JC, Brodsy I Effects of tramexanic acid on platelet ADP during extracorporeal circulation. Am J Hematol 1991;38 113-9
19. Royston D. High-dose aprotinin therapy: a review of the five years experience. J Cardiothorac Anesth 1992;6:76-100.
20. Van Oevaren W, Harder HP, Roozendoral KJ, Eijsman L, Wildevur CRM. Aprotinin protects platelets against the initial effect of cardiopulmonary bypass. J Thorac Cardiovasc Surg 1990;99:788-97.
21. Adelman B, Michelson AD, Loscalzo J, Greenberg J, Handin RI. Plasmin effect on platelet glycoprotein I b-von Willebrand factor interaction. Blood 1985,65:32-40
22. Campbell FW. The contribution of platelet dysfunction to post bypass bleeding. J Cardiothorac Anesth 1991.5(Suppl 1). 8-12
23. Rinder CS, Matehw JP, Rinder HM, Bonan J, Ault KA, Smith BR Modulation of platelet surface adhesion receptors during cardiopulmonary bypass Anesthesiology 1991;75:563-70
24. Tnuh-Due P, Wintrebert P, Boulfroy D, Albet B. Comparaison des effects de l'acide aminocaproique et de l'aprotinine sur le saignement per et postoperative en chirurgie cardiaque. Am Chir 1992;46-677-83.